Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)

Post Date

November 22nd 2006

Application Due Date

November 30th -0001

Multiple Receipt Dates - See Link to Full Announcement for details.

Funding Opportunity Number

PA-07-093

CFDA Number(s)

93.867

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
Public and State Controlled Institutions of Higher Education
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply.

Funding

• Award Range:

  $None - $None

Grant Description

-Purpose. Scientific cooperation between India and the U.S. has taken place under a variety of bilateral umbrella agreements, including the Indo-U.S. Science and Technology (S and T) Sub-Commission, the Gandhi-Reagan S and T Initiative, the U.S.-India Fund, and the current S and T Cooperation Agreement. Building upon these agreements and initiatives, representatives of the United States and the Government of India signed a Memorandum of Understanding on July, 9 1987 implementing the Indo-U.S. Vaccine Action Program (VAP) in order to expand collaborative vaccine research. The goal of the VAP is to support collaborative vaccine-related research projects that ultimately reduce the burden of infectious diseases of importance in India, the U.S., the South Asian region and globally. -Mechanism of Support. This funding opportunity announcement (FOA) solicits Small Research Grant (R03) applications, which will provide U.S. dollar support of vaccine-related research in India and the United States and augment current VAP activities. Investigators from U.S. and Indian institutions are eligible to apply. -Applications are solicited from organizations/institutions that propose to conduct vaccine-related research through well-established collaborations with Indian investigators on the following: dengue, influenza (including avian influenza), HIV/AIDS, and tuberculosis.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PA-07-093.html